1,2-dimethylhydrazine multiple interactions ISO Map1lc3a (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAP1LC3A mRNA CTD PMID:22206623 1,3-dichloropropan-2-ol decreases expression EXP 6480464 1 and 3-dichloro-2-propanol results in decreased expression of MAP1LC3A protein CTD PMID:36000575 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of MAP1LC3A mRNA CTD PMID:25380136 17alpha-ethynylestradiol affects expression ISO Map1lc3a (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of MAP1LC3A mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO Map1lc3a (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAP1LC3A mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of MAP1LC3A mRNA CTD PMID:17351261 2,2-(2-Chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene increases expression ISO Map1lc3a (Mus musculus) 6480464 2 more ... CTD PMID:32721735 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO Map1lc3a (Mus musculus) 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Map1lc3a (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MAP1LC3A mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of MAP1LC3A mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MAP1LC3A mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Map1lc3a (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MAP1LC3A mRNA CTD PMID:21570461 and PMID:24680724 2-deoxy-D-glucose multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 Deoxyglucose affects the reaction [demycarosyl-3D-digitoxosylmithramycin SK affects the expression of MAP1LC3A mRNA] CTD PMID:26079942 2-hydroxypropanoic acid decreases expression ISO MAP1LC3A (Homo sapiens) 6480464 Lactic Acid results in decreased expression of MAP1LC3A mRNA CTD PMID:30851411 3,4-methylenedioxymethamphetamine increases expression ISO Map1lc3a (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of MAP1LC3A mRNA CTD PMID:20188158 3-methyladenine multiple interactions ISO Map1lc3a (Mus musculus) 6480464 3-methyladenine inhibits the reaction [sodium arsenite results in increased expression of MAP1LC3A protein modified form] CTD PMID:20008137 3-methyladenine multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [alisol A 24-acetate results in increased expression of MAP1LC3A protein] and 3-methyladenine inhibits the reaction [alisol B 23-acetate results in increased expression of MAP1LC3A protein] CTD PMID:28408883 3-methyladenine affects metabolic processing ISO MAP1LC3A (Homo sapiens) 6480464 3-methyladenine affects the metabolism of MAP1LC3A protein CTD PMID:21742779 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of MAP1LC3A mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MAP1LC3A mRNA CTD PMID:36041667 4-aminopyridine increases expression EXP 6480464 4-Aminopyridine results in increased expression of MAP1LC3A mRNA CTD PMID:24378259 4-nonylphenol increases expression EXP 6480464 4-nonylphenol results in increased expression of MAP1LC3A mRNA CTD PMID:30228064 5-aza-2'-deoxycytidine affects expression ISO MAP1LC3A (Homo sapiens) 6480464 Decitabine affects the expression of MAP1LC3A mRNA CTD PMID:23300844 5-chloro-7-iodoquinolin-8-ol increases expression ISO MAP1LC3A (Homo sapiens) 6480464 Clioquinol results in increased expression of MAP1LC3A protein CTD PMID:36396104 abamectin increases expression EXP 6480464 abamectin results in increased expression of MAP1LC3A mRNA CTD PMID:34748272 abamectin multiple interactions EXP 6480464 Hesperidin inhibits the reaction [abamectin results in increased expression of MAP1LC3A mRNA] CTD PMID:34748272 acadesine multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 acadesine promotes the reaction [Capsaicin affects the localization of MAP1LC3A protein] CTD PMID:36044967 acetamide increases expression EXP 6480464 acetamide results in increased expression of MAP1LC3A mRNA CTD PMID:31881176 acrylonitrile increases expression ISO Map1lc3a (Mus musculus) 6480464 Acrylonitrile results in increased expression of MAP1LC3A mRNA CTD PMID:35429547 aflatoxin B1 increases expression ISO MAP1LC3A (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of MAP1LC3A mRNA CTD PMID:34396909 Alisol B increases expression ISO MAP1LC3A (Homo sapiens) 6480464 alisol B results in increased expression of MAP1LC3A protein CTD PMID:20197400 allethrin increases expression EXP 6480464 Allethrins results in increased expression of MAP1LC3A mRNA and Allethrins results in increased expression of MAP1LC3A protein CTD PMID:35742842 alpha,alpha-trehalose increases expression ISO Map1lc3a (Mus musculus) 6480464 Trehalose results in increased expression of MAP1LC3A mRNA CTD PMID:23851366 amitrole multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 Amitrole inhibits the reaction [dihydrocapsaicin results in increased expression of MAP1LC3A protein] CTD PMID:18818525 ammonium chloride decreases degradation ISO MAP1LC3A (Homo sapiens) 6480464 Ammonium Chloride results in decreased degradation of MAP1LC3A protein alternative form CTD PMID:21742779 anthra[1,9-cd]pyrazol-6(2H)-one decreases expression EXP 329853763 SP600125 decreases expression of protein in oxygen-glucose deprived rat neuronal PC12 cells RGD antirheumatic drug increases expression ISO MAP1LC3A (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of MAP1LC3A mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO MAP1LC3A (Homo sapiens) 6480464 aristolochic acid I results in increased expression of MAP1LC3A mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased lipidation of MAP1LC3A protein CTD PMID:31781319 arsenous acid increases expression ISO MAP1LC3A (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of MAP1LC3A protein CTD PMID:20200477 arsenous acid increases expression ISO Map1lc3a (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of MAP1LC3A mRNA CTD PMID:30032600 more ... bafilomycin A1 multiple interactions ISO Map1lc3a (Mus musculus) 6480464 bafilomycin A1 promotes the reaction [Uranium results in increased expression of MAP1LC3A protein] CTD PMID:31120128 bafilomycin A1 increases expression ISO MAP1LC3A (Homo sapiens) 6480464 bafilomycin A1 results in increased expression of MAP1LC3A protein modified form CTD PMID:30871063 benzo[a]pyrene increases methylation ISO MAP1LC3A (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of MAP1LC3A 5' UTR more ... CTD PMID:27901495 benzo[a]pyrene increases expression ISO MAP1LC3A (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of MAP1LC3A mRNA CTD PMID:34332006 bis(2-chloroethyl) sulfide increases expression ISO MAP1LC3A (Homo sapiens) 6480464 Mustard Gas results in increased expression of MAP1LC3A mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate increases expression ISO Map1lc3a (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of MAP1LC3A mRNA CTD PMID:21318169 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of MAP1LC3A mRNA CTD PMID:25181051 bisphenol A affects localization ISO Map1lc3a (Mus musculus) 6480464 bisphenol A affects the localization of MAP1LC3A protein CTD PMID:35357751 bisphenol A decreases expression ISO Map1lc3a (Mus musculus) 6480464 bisphenol A results in decreased expression of MAP1LC3A mRNA CTD PMID:35598803 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MAP1LC3A mRNA CTD PMID:36041667 bisphenol A increases expression ISO Map1lc3a (Mus musculus) 6480464 bisphenol A results in increased expression of MAP1LC3A mRNA CTD PMID:34281243 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MAP1LC3A mRNA CTD PMID:30816183 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MAP1LC3A mRNA CTD PMID:27539358 more ... bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of MAP1LC3A mRNA CTD PMID:36041667 butanal increases expression ISO MAP1LC3A (Homo sapiens) 6480464 butyraldehyde results in increased expression of MAP1LC3A mRNA CTD PMID:26079696 cadmium atom increases expression ISO Map1lc3a (Mus musculus) 6480464 Cadmium results in increased expression of MAP1LC3A mRNA CTD PMID:37270049 cadmium dichloride multiple interactions ISO Map1lc3a (Mus musculus) 6480464 Chloroquine affects the reaction [Cadmium Chloride results in increased expression of MAP1LC3A protein] CTD PMID:35843418 cadmium dichloride affects expression ISO Map1lc3a (Mus musculus) 6480464 Cadmium Chloride affects the expression of MAP1LC3A protein CTD PMID:35843418 cadmium dichloride increases expression ISO Map1lc3a (Mus musculus) 6480464 Cadmium Chloride results in increased expression of MAP1LC3A protein CTD PMID:35843418 cadmium sulfide decreases expression ISO MAP1LC3A (Homo sapiens) 6480464 cadmium sulfide results in decreased expression of MAP1LC3A mRNA CTD PMID:27866839 calyculin a increases expression ISO Map1lc3a (Mus musculus) 6480464 calyculin A results in increased expression of MAP1LC3A mRNA CTD PMID:25270620 capsaicin affects localization ISO MAP1LC3A (Homo sapiens) 6480464 Capsaicin affects the localization of MAP1LC3A protein CTD PMID:36044967 capsaicin multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 acadesine promotes the reaction [Capsaicin affects the localization of MAP1LC3A protein] and dorsomorphin inhibits the reaction [Capsaicin affects the localization of MAP1LC3A protein] CTD PMID:36044967 carbamazepine multiple interactions EXP 6480464 [Dietary Fats co-treated with Streptozocin co-treated with Carbamazepine] results in increased expression of MAP1LC3A protein CTD PMID:35786680 carbon nanotube increases expression ISO MAP1LC3A (Homo sapiens) 6480464 Nanotubes and Carbon results in increased expression of MAP1LC3A mRNA CTD PMID:29348435 CGP 52608 multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to MAP1LC3A gene] CTD PMID:28238834 CHIR 99021 multiple interactions ISO Map1lc3a (Mus musculus) 6480464 Chir 99021 inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3A protein] CTD PMID:30165626 chloroquine increases expression ISO MAP1LC3A (Homo sapiens) 6480464 Chloroquine results in increased expression of MAP1LC3A protein and Chloroquine results in increased expression of MAP1LC3A protein modified form CTD PMID:30280407 and PMID:30871063 chloroquine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [doramectin results in decreased expression of and results in increased lipidation of MAP1LC3A protein] and Chloroquine inhibits the reaction [doramectin results in decreased expression of MAP1LC3A protein] CTD PMID:35137919 chloroquine multiple interactions ISO Map1lc3a (Mus musculus) 6480464 Chloroquine affects the reaction [Cadmium Chloride results in increased expression of MAP1LC3A protein] CTD PMID:35843418 chloroquine multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 Chloroquine inhibits the reaction [hydroquinone results in increased degradation of MAP1LC3A protein] CTD PMID:35302183 chlorpyrifos increases expression ISO Map1lc3a (Mus musculus) 6480464 Chlorpyrifos results in increased expression of MAP1LC3A mRNA CTD PMID:27737797 chlorpyrifos multiple interactions ISO Map1lc3a (Mus musculus) 6480464 [Paraquat co-treated with Chlorpyrifos] results in decreased expression of MAP1LC3A protein CTD PMID:26884967 cisplatin affects expression ISO MAP1LC3A (Homo sapiens) 6480464 Cisplatin affects the expression of MAP1LC3A mRNA CTD PMID:23300844 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of MAP1LC3A protein CTD PMID:25598344 cisplatin multiple interactions EXP 6480464 saponin Rb1 and Panax notoginsenoside promotes the reaction [Cisplatin results in increased expression of MAP1LC3A protein] CTD PMID:25598344 cisplatin multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of MAP1LC3A mRNA CTD PMID:30871063 cisplatin decreases expression ISO MAP1LC3A (Homo sapiens) 6480464 Cisplatin results in decreased expression of MAP1LC3A mRNA CTD PMID:27392435 clofibrate multiple interactions ISO Map1lc3a (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MAP1LC3A mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MAP1LC3A mRNA] CTD PMID:17585979 clofibrate decreases expression ISO Map1lc3a (Mus musculus) 6480464 Clofibrate results in decreased expression of MAP1LC3A mRNA CTD PMID:17585979 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAP1LC3A mRNA CTD PMID:17602206 cocaine affects expression EXP 6480464 Cocaine affects the expression of MAP1LC3A mRNA CTD PMID:20187946 copper atom multiple interactions ISO Map1lc3a (Mus musculus) 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of MAP1LC3A protein CTD PMID:31491480 copper(0) multiple interactions ISO Map1lc3a (Mus musculus) 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of MAP1LC3A protein CTD PMID:31491480 copper(II) sulfate increases expression ISO MAP1LC3A (Homo sapiens) 6480464 Copper Sulfate results in increased expression of MAP1LC3A mRNA CTD PMID:19549813 copper(II) sulfate multiple interactions ISO Map1lc3a (Mus musculus) 6480464 [Copper Sulfate results in increased abundance of Copper] which results in increased expression of MAP1LC3A protein CTD PMID:31491480 cordycepin increases expression ISO MAP1LC3A (Homo sapiens) 6480464 cordycepin results in increased expression of MAP1LC3A mRNA CTD PMID:28987792 cyfluthrin increases expression EXP 6480464 cyfluthrin results in increased expression of MAP1LC3A mRNA CTD PMID:36515635 cyfluthrin increases expression ISO Map1lc3a (Mus musculus) 6480464 cyfluthrin results in increased expression of MAP1LC3A mRNA CTD PMID:36515635 cypermethrin increases expression ISO MAP1LC3A (Homo sapiens) 6480464 cypermethrin results in increased expression of MAP1LC3A mRNA CTD PMID:27704156 cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of MAP1LC3A mRNA CTD PMID:35876585 dactolisib increases metabolic processing ISO MAP1LC3A (Homo sapiens) 6480464 dactolisib results in increased metabolism of MAP1LC3A protein CTD PMID:23651616 dactolisib affects localization ISO MAP1LC3A (Homo sapiens) 6480464 dactolisib affects the localization of MAP1LC3A protein CTD PMID:23651616 DDE affects expression ISO Map1lc3a (Mus musculus) 6480464 Dichlorodiphenyl Dichloroethylene affects the expression of MAP1LC3A mRNA CTD PMID:32721735 DDE increases expression ISO Map1lc3a (Mus musculus) 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of MAP1LC3A protein CTD PMID:32721735 desferrioxamine B multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 Deferoxamine inhibits the reaction [Hydrogen Peroxide affects the localization of MAP1LC3A protein] CTD PMID:21742779 diarsenic trioxide increases expression ISO MAP1LC3A (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of MAP1LC3A protein CTD PMID:20200477 diarsenic trioxide increases expression ISO Map1lc3a (Mus musculus) 6480464 Arsenic Trioxide results in increased expression of MAP1LC3A mRNA CTD PMID:30032600 more ... dihydrocapsaicin multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 Amitrole inhibits the reaction [dihydrocapsaicin results in increased expression of MAP1LC3A protein] more ... CTD PMID:18818525 dihydrocapsaicin increases expression ISO MAP1LC3A (Homo sapiens) 6480464 dihydrocapsaicin results in increased expression of MAP1LC3A protein CTD PMID:18818525 Doramectin multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 doramectin results in increased expression of and results in increased lipidation of MAP1LC3A protein CTD PMID:35137919 Doramectin multiple interactions EXP 6480464 Chloroquine inhibits the reaction [doramectin results in decreased expression of and results in increased lipidation of MAP1LC3A protein] more ... CTD PMID:35137919 dorsomorphin multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 dorsomorphin inhibits the reaction [Capsaicin affects the localization of MAP1LC3A protein] and dorsomorphin inhibits the reaction [sulphoraphene results in increased expression of MAP1LC3A protein] CTD PMID:29247643 and PMID:36044967 doxorubicin affects expression ISO MAP1LC3A (Homo sapiens) 6480464 Doxorubicin affects the expression of MAP1LC3A mRNA CTD PMID:26969377 doxorubicin multiple interactions EXP 6480464 HDAC6 protein affects the reaction [Doxorubicin affects the localization of MAP1LC3A protein] and NLRP3 protein affects the reaction [HDAC6 protein affects the reaction [Doxorubicin affects the localization of MAP1LC3A protein]] CTD PMID:35764897 doxorubicin affects localization EXP 6480464 Doxorubicin affects the localization of MAP1LC3A protein CTD PMID:35764897 doxorubicin multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 [Doxorubicin co-treated with resveratrol] results in decreased expression of MAP1LC3A mRNA CTD PMID:26969377 epoxiconazole increases expression ISO Map1lc3a (Mus musculus) 6480464 epoxiconazole results in increased expression of MAP1LC3A mRNA CTD PMID:35436446 ethanol affects splicing ISO Map1lc3a (Mus musculus) 6480464 Ethanol affects the splicing of MAP1LC3A mRNA CTD PMID:30319688 ethanol multiple interactions ISO Map1lc3a (Mus musculus) 6480464 Thymol inhibits the reaction [Ethanol results in increased expression of MAP1LC3A protein] CTD PMID:36535314 ethanol increases expression ISO Map1lc3a (Mus musculus) 6480464 Ethanol results in increased expression of MAP1LC3A mRNA and Ethanol results in increased expression of MAP1LC3A protein CTD PMID:30319688 and PMID:36535314 fenofibrate increases expression ISO Map1lc3a (Mus musculus) 6480464 Fenofibrate results in increased expression of MAP1LC3A mRNA CTD PMID:21318169 fenofibrate multiple interactions ISO Map1lc3a (Mus musculus) 6480464 [PPARA protein affects the susceptibility to Fenofibrate] which affects the expression of MAP1LC3A mRNA CTD PMID:21318169 fenthion increases expression ISO Map1lc3a (Mus musculus) 6480464 Fenthion results in increased expression of MAP1LC3A mRNA CTD PMID:34813904 ferric oxide increases expression ISO Map1lc3a (Mus musculus) 6480464 ferric oxide analog results in increased expression of MAP1LC3A protein CTD PMID:25086211 folic acid multiple interactions ISO Map1lc3a (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MAP1LC3A mRNA CTD PMID:22206623 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of MAP1LC3A mRNA CTD PMID:22061828 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MAP1LC3A mRNA CTD PMID:33387578 glyphosate increases expression ISO Map1lc3a (Mus musculus) 6480464 Glyphosate results in increased expression of MAP1LC3A mRNA CTD PMID:31352102 hesperidin multiple interactions EXP 6480464 Hesperidin inhibits the reaction [abamectin results in increased expression of MAP1LC3A mRNA] more ... CTD PMID:34748272 more ... hydrogen peroxide multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 Deferoxamine inhibits the reaction [Hydrogen Peroxide affects the localization of MAP1LC3A protein] CTD PMID:21742779 hydrogen peroxide increases metabolic processing ISO MAP1LC3A (Homo sapiens) 6480464 Hydrogen Peroxide results in increased metabolism of MAP1LC3A protein CTD PMID:21742779 hydrogen peroxide affects localization ISO MAP1LC3A (Homo sapiens) 6480464 Hydrogen Peroxide affects the localization of MAP1LC3A protein CTD PMID:21742779 hydroquinone multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 Chloroquine inhibits the reaction [hydroquinone results in increased degradation of MAP1LC3A protein] and hydroquinone affects the localization of and results in increased degradation of MAP1LC3A protein CTD PMID:35302183 ivermectin decreases expression ISO MAP1LC3A (Homo sapiens) 6480464 Ivermectin results in decreased expression of MAP1LC3A protein CTD PMID:32959892 lead(0) affects expression ISO MAP1LC3A (Homo sapiens) 6480464 Lead affects the expression of MAP1LC3A mRNA CTD PMID:28903495 LY294002 multiple interactions ISO Map1lc3a (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of MAP1LC3A mRNA]] and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of MAP1LC3A mRNA] CTD PMID:35568058 melatonin multiple interactions ISO Map1lc3a (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of MAP1LC3A mRNA]] and Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of MAP1LC3A mRNA] CTD PMID:35568058 methidathion increases expression ISO Map1lc3a (Mus musculus) 6480464 methidathion results in increased expression of MAP1LC3A mRNA CTD PMID:34813904 N-methyl-4-phenylpyridinium decreases expression ISO Map1lc3a (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3A mRNA and 1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3A protein CTD PMID:30165626 N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 Imatinib Mesylate inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3A protein] CTD PMID:30165626 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3A protein CTD PMID:30165626 N-methyl-4-phenylpyridinium multiple interactions ISO Map1lc3a (Mus musculus) 6480464 Chir 99021 inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3A protein] and Imatinib Mesylate inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of MAP1LC3A protein] CTD PMID:30165626 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of MAP1LC3A mRNA CTD PMID:17602206 nickel atom decreases expression ISO MAP1LC3A (Homo sapiens) 6480464 Nickel results in decreased expression of MAP1LC3A mRNA CTD PMID:24768652 and PMID:25583101 nickel atom multiple interactions ISO Map1lc3a (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of MAP1LC3A mRNA]] more ... CTD PMID:35568058 nickel dichloride multiple interactions ISO Map1lc3a (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Melatonin inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased expression of MAP1LC3A mRNA]] more ... CTD PMID:35568058 Nonylphenol increases expression EXP 6480464 nonylphenol results in increased expression of MAP1LC3A mRNA CTD PMID:27832966 okadaic acid increases expression ISO Map1lc3a (Mus musculus) 6480464 Okadaic Acid results in increased expression of MAP1LC3A mRNA CTD PMID:25270620 ozone multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of MAP1LC3A mRNA CTD PMID:35430440 paclitaxel multiple interactions EXP 6480464 Hesperidin inhibits the reaction [Paclitaxel results in increased expression of MAP1LC3A mRNA] CTD PMID:35921949 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of MAP1LC3A mRNA CTD PMID:35921949 paracetamol multiple interactions ISO Map1lc3a (Mus musculus) 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MAP1LC3A mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MAP1LC3A mRNA] CTD PMID:17585979 paracetamol increases expression ISO Map1lc3a (Mus musculus) 6480464 Acetaminophen results in increased expression of MAP1LC3A mRNA CTD PMID:37179516 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MAP1LC3A mRNA CTD PMID:33387578 paracetamol increases expression ISO MAP1LC3A (Homo sapiens) 6480464 Acetaminophen results in increased expression of MAP1LC3A mRNA CTD PMID:29067470 paracetamol affects expression ISO Map1lc3a (Mus musculus) 6480464 Acetaminophen affects the expression of MAP1LC3A mRNA CTD PMID:17562736 paraquat increases expression ISO Map1lc3a (Mus musculus) 6480464 Paraquat results in increased expression of MAP1LC3A protein CTD PMID:22982048 paraquat multiple interactions ISO Map1lc3a (Mus musculus) 6480464 [Paraquat co-treated with Chlorpyrifos] results in decreased expression of MAP1LC3A protein CTD PMID:26884967 paraquat multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 ATG5 protein affects the reaction [Paraquat results in increased expression of MAP1LC3A protein] and ATP6V0A1 protein affects the reaction [Paraquat results in increased expression of MAP1LC3A protein] CTD PMID:22982048 paraquat increases expression ISO MAP1LC3A (Homo sapiens) 6480464 Paraquat results in increased expression of MAP1LC3A protein CTD PMID:22982048 perfluorooctanoic acid multiple interactions ISO Map1lc3a (Mus musculus) 6480464 PPARA protein affects the reaction [perfluorooctanoic acid results in increased expression of MAP1LC3A mRNA] CTD PMID:21318169 perfluorooctanoic acid increases expression ISO MAP1LC3A (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of MAP1LC3A protein modified form CTD PMID:26879310 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of MAP1LC3A mRNA CTD PMID:19162173 and PMID:21318169 perfluorooctanoic acid increases expression ISO Map1lc3a (Mus musculus) 6480464 perfluorooctanoic acid results in increased expression of MAP1LC3A mRNA and perfluorooctanoic acid results in increased expression of MAP1LC3A protein modified form CTD PMID:21318169 and PMID:26879310 perfluoroundecanoic acid decreases expression EXP 6480464 perfluoroundecanoic acid results in decreased expression of MAP1LC3A protein CTD PMID:33549592 picoxystrobin decreases expression ISO MAP1LC3A (Homo sapiens) 6480464 picoxystrobin results in decreased expression of MAP1LC3A mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO Map1lc3a (Mus musculus) 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of MAP1LC3A mRNA] CTD PMID:21318169 pirinixic acid increases expression ISO Map1lc3a (Mus musculus) 6480464 pirinixic acid results in increased expression of MAP1LC3A mRNA CTD PMID:18301758 more ... platycodin D multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 U 0126 inhibits the reaction [platycodin D results in increased expression of MAP1LC3A protein] CTD PMID:25592318 platycodin D increases expression ISO MAP1LC3A (Homo sapiens) 6480464 platycodin D results in increased expression of MAP1LC3A protein CTD PMID:25592318 ponatinib increases lipidation ISO MAP1LC3A (Homo sapiens) 6480464 ponatinib results in increased lipidation of MAP1LC3A protein CTD PMID:29341879 rac-lactic acid decreases expression ISO MAP1LC3A (Homo sapiens) 6480464 Lactic Acid results in decreased expression of MAP1LC3A mRNA CTD PMID:30851411 resorcinol increases lipidation ISO MAP1LC3A (Homo sapiens) 6480464 resorcinol analog results in increased lipidation of MAP1LC3A protein CTD PMID:24910342 resveratrol multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 [Doxorubicin co-treated with resveratrol] results in decreased expression of MAP1LC3A mRNA CTD PMID:26969377 resveratrol decreases expression ISO MAP1LC3A (Homo sapiens) 6480464 resveratrol results in decreased expression of MAP1LC3A mRNA CTD PMID:26969377 rotenone decreases expression ISO Map1lc3a (Mus musculus) 6480464 Rotenone results in decreased expression of MAP1LC3A mRNA CTD PMID:23186747 SB 203580 decreases expression EXP 329853763 SB203580 decreases expression of protein in oxygen-glucose deprived rat neuronal PC12 cells RGD sirolimus multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 [Sirolimus inhibits the reaction [MTOR protein binds to RPTOR protein]] which results in increased expression of MAP1LC3A protein alternative form CTD PMID:21742779 sodium arsenite multiple interactions ISO Map1lc3a (Mus musculus) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased expression of MAP1LC3A protein modified form] more ... CTD PMID:20008137 and PMID:30097599 sodium arsenite multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of arsenite] which results in increased lipidation of MAP1LC3A protein CTD PMID:31781319 sodium arsenite increases expression ISO Map1lc3a (Mus musculus) 6480464 sodium arsenite results in increased expression of MAP1LC3A mRNA and sodium arsenite results in increased expression of MAP1LC3A protein modified form CTD PMID:20008137 and PMID:30097599 sodium fluoride increases expression ISO Map1lc3a (Mus musculus) 6480464 Sodium Fluoride results in increased expression of MAP1LC3A mRNA CTD PMID:24296261 sodium fluoride multiple interactions EXP 6480464 Hesperidin inhibits the reaction [Sodium Fluoride results in increased expression of MAP1LC3A protein] CTD PMID:35413380 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of MAP1LC3A mRNA and Sodium Fluoride results in increased expression of MAP1LC3A protein CTD PMID:24296261 and PMID:35413380 Soman increases expression EXP 6480464 Soman results in increased expression of MAP1LC3A mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 [Dietary Fats co-treated with Streptozocin co-treated with Carbamazepine] results in increased expression of MAP1LC3A protein CTD PMID:35786680 sunitinib decreases expression ISO MAP1LC3A (Homo sapiens) 6480464 Sunitinib results in decreased expression of MAP1LC3A mRNA CTD PMID:31533062 tamoxifen affects expression ISO Map1lc3a (Mus musculus) 6480464 Tamoxifen affects the expression of MAP1LC3A mRNA CTD PMID:17555576 temozolomide decreases expression ISO MAP1LC3A (Homo sapiens) 6480464 Temozolomide results in decreased expression of MAP1LC3A mRNA CTD PMID:31758290 testosterone increases expression ISO Map1lc3a (Mus musculus) 6480464 Testosterone results in increased expression of MAP1LC3A mRNA CTD PMID:20403060 tetrachloromethane affects expression ISO Map1lc3a (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of MAP1LC3A mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO Map1lc3a (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of MAP1LC3A mRNA CTD PMID:31919559 thymol increases expression ISO Map1lc3a (Mus musculus) 6480464 Thymol results in increased expression of MAP1LC3A protein CTD PMID:36535314 thymol multiple interactions ISO Map1lc3a (Mus musculus) 6480464 Thymol inhibits the reaction [Ethanol results in increased expression of MAP1LC3A protein] CTD PMID:36535314 thymol sulfate(1-) increases expression ISO Map1lc3a (Mus musculus) 6480464 Thymol results in increased expression of MAP1LC3A protein CTD PMID:36535314 thymol sulfate(1-) multiple interactions ISO Map1lc3a (Mus musculus) 6480464 Thymol inhibits the reaction [Ethanol results in increased expression of MAP1LC3A protein] CTD PMID:36535314 thymoquinone increases lipidation ISO MAP1LC3A (Homo sapiens) 6480464 thymoquinone results in increased lipidation of MAP1LC3A protein CTD PMID:31298468 titanium dioxide decreases expression ISO Map1lc3a (Mus musculus) 6480464 titanium dioxide results in decreased expression of MAP1LC3A mRNA CTD PMID:23557971 toluene decreases expression EXP 6480464 Toluene results in decreased expression of MAP1LC3A mRNA CTD PMID:22967744 trovafloxacin multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 TNF protein inhibits the reaction [trovafloxacin results in increased expression of MAP1LC3A mRNA] CTD PMID:33609687 trovafloxacin increases expression ISO MAP1LC3A (Homo sapiens) 6480464 trovafloxacin results in increased expression of MAP1LC3A mRNA CTD PMID:33609687 uranium atom multiple interactions ISO Map1lc3a (Mus musculus) 6480464 bafilomycin A1 promotes the reaction [Uranium results in increased expression of MAP1LC3A protein] CTD PMID:31120128 uranium atom increases expression ISO Map1lc3a (Mus musculus) 6480464 Uranium results in increased expression of MAP1LC3A protein CTD PMID:31120128 valproic acid affects expression ISO Map1lc3a (Mus musculus) 6480464 Valproic Acid affects the expression of MAP1LC3A mRNA CTD PMID:17963808 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of MAP1LC3A mRNA CTD PMID:21318169 valproic acid increases expression ISO Map1lc3a (Mus musculus) 6480464 Valproic Acid results in increased expression of MAP1LC3A mRNA CTD PMID:20546886 and PMID:21427059 valproic acid affects expression ISO MAP1LC3A (Homo sapiens) 6480464 Valproic Acid affects the expression of MAP1LC3A mRNA CTD PMID:25979313 valproic acid increases methylation ISO MAP1LC3A (Homo sapiens) 6480464 Valproic Acid results in increased methylation of MAP1LC3A gene CTD PMID:29154799 vemurafenib multiple interactions ISO MAP1LC3A (Homo sapiens) 6480464 [Vemurafenib co-treated with 3 and 5-bis((4-nitrophenyl)methylidene)-1-prop-2-enoylpiperidin-4-one] affects the localization of MAP1LC3A protein CTD PMID:35648318 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of MAP1LC3A mRNA CTD PMID:23034163 XL147 multiple interactions ISO Map1lc3a (Mus musculus) 6480464 XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of MAP1LC3A mRNA] CTD PMID:29891994 zearalenone increases expression ISO Map1lc3a (Mus musculus) 6480464 Zearalenone results in increased expression of MAP1LC3A mRNA CTD PMID:34537261 zerumbone decreases expression ISO MAP1LC3A (Homo sapiens) 6480464 zerumbone results in decreased expression of MAP1LC3A mRNA CTD PMID:36122806
